Industries > Pharma > Alopecia Market Report to 2031
Alopecia Market Report to 2031
Forecasts by Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, and Alopecia Totalis), By Route of Administration (Oral, Topical, and Injectable), By Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies) PLUS COVID-19 Recovery Scenarios
Alopecia Market – our new study reveals trends, R&D progress, and predicted revenues
Where is the Alopecia market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 500+ page report provides 600+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Alopecia Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Alopecia Market: By Disease Type
• Androgenic Alopecia
• Alopecia Areata
• Ciatricial Alopecia
• Traction Alopecia
• Alopecia Totalis
Alopecia Market: By Route of Administration
• Oral
• Topical
• Injectable
Alopecia Market: By Distribution Channel
• Hospitals
• Retail Pharmacies
• Online Pharmacies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East and Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Alopecia Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Alopecia Market will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Alopecia Market report helps you
In summary, our 500+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Alopecia Market, with forecasts for Disease Type, Route of Administration, and Distribution Channel, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Alopecia market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Alopecia Market. Some of the company’s profiled in this report include Johnson and Johnson Services, Inc.; Sun Pharmaceutical Industries Ltd.; Cipla Inc.; Lexington International LLC; Merck & Co., Inc.; Vita-Cos-Med Klett-Loch GmbH; Cirrus Hair Centers; Transitions Hair Pty Ltd.; Capillus; and Follica, Inc.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Alopecia Market Report to 2031: Forecasts by Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, and Alopecia Totalis), By Route of Administration (Oral, Topical, and Injectable), By Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies) PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Alopecia Market
2.1. Alopecia Market Definition
2.2. Disease Type Submarkets Definitions
2.3. Route of Administration Submarkets Definitions
2.4. Distribution Channel Submarkets Definitions
3. Alopecia Market Overview
3.1. Global Alopecia Market Size and Forecast by Region
3.2. Global Alopecia Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing global prevalence of alopecia
3.3.1.2. Growing incidence of chronic diseases
3.3.2. Market Restraints/Challenges
3.3.2.1. Lack of reimbursement policies
3.3.3. Opportunities
3.3.3.1. Rise in global healthcare expenditure
3.3.3.2. Technological advancements in alopecia treatment
3.3.4. Global Alopecia Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Alopecia Market Analysis and Forecast, 2021-2031 by Disease Type (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Androgenic Alopecia
4.1.2. Alopecia Areata
4.1.3. Ciatricial Alopecia
4.1.4. Traction Alopecia
4.1.5. Alopecia Totalis
5. Global Alopecia Market Analysis and Forecast 2021-2031, by Route of Administration (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Oral
5.1.2. Topical
5.1.3. Injectable
6. Global Alopecia Market Analysis and Forecast, 2021-2031 by Distribution Channel (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Hospital Pharmacy
6.1.2. Retail Pharmacy
6.1.3. Online Pharmacy
7. North America Alopecia Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Alopecia Market Size and Forecast by Disease Type
7.3. North America Alopecia Market Size and Forecast by Route of Administration
7.4. North America Alopecia Market Size and Forecast by Distribution Channel
7.5. U.S. Alopecia Market
7.6. Canada Alopecia Market
8. Europe Alopecia Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Alopecia Market Size and Forecast by Disease Type
8.3. Europe Alopecia Market Size and Forecast by Route of Administration
8.4. Europe Alopecia Market Size and Forecast by Distribution Channel
8.5. UK Alopecia Market
8.6. Germany Alopecia Market
8.7. France Alopecia Market
8.8. Rest of Europe Alopecia Market
9. Asia Pacific Alopecia Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Alopecia Market Size and Forecast by Disease Type
9.3. Asia Pacific Alopecia Market Size and Forecast by Route of Administration
9.4. Asia Pacific Alopecia Market Size and Forecast by Distribution Channel
9.5. China Alopecia Market
9.6. India Alopecia Market
9.7. Japan Alopecia Market
9.8. Rest of Asia Pacific Alopecia Market
10. Latin America Alopecia Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Alopecia Market Size and Forecast by Disease Type
10.3. Latin America Alopecia Market Size and Forecast by Route of Administration
10.4. Latin America Alopecia Market Size and Forecast by Distribution Channel
10.4.1. Brazil Alopecia Market
10.4.2. Mexico Alopecia Market
10.4.3. Rest of Latin America Alopecia Market
11. MEA Alopecia Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Alopecia Market Size and Forecast by Disease Type
11.3. MEA Alopecia Market Size and Forecast by Route of Administration
11.4. MEA Alopecia Market Size and Forecast by Distribution Channel
11.5. GCC Alopecia Market
11.6. South Africa Alopecia Market
11.7. Rest of MEA Alopecia Market
12. Companies in the Alopecia Market
12.1. Johnson and Johnson Services, Inc.
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2019)
12.2. Sun Pharmaceutical Industries Ltd.
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2019)
12.3. Cipla Inc.
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2019)
12.4. Lexington International LLC
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2019)
12.5. Merck & Co., Inc.
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2019)
12.6. Vita-Cos-Med Klett-Loch GmbH
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2019)
12.7. Cirrus Hair Centers
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2019)
12.8. Transitions Hair Pty Ltd.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2019)
12.9. Capillus
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2019)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2019
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2019)
12.10. Follica, Inc.
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2019
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2019)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Alopecia Market Drivers & Restraints 2020
Table 7 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 8 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 18 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 19 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 20 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 21 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 22 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 23 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 24 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 25 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 26 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 27 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 28 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 29 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 30 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 31 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 32 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 33 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 34 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 35 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 36 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 37 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 38 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 39 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 40 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 41 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 42 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 43 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 44 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 45 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 46 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 47 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 48 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 49 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 50 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 51 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 52 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 53 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 54 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 55 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 56 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 57 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 58 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 59 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 60 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 61 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 62 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 63 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 64 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 65 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 66 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 67 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 68 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 69 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 70 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 71 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 72 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 73 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 74 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 75 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 76 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 77 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 78 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 79 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 80 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 81 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 82 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 83 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 84 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 85 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 86 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 87 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 88 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 89 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 90 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 91 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 92 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 93 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 94 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 95 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 96 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 97 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 98 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 99 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 100 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 101 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 102 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 103 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 104 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 105 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 106 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 107 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 108 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 109 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 110 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 111 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 112 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 113 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 114 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 115 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 116 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 117 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 118 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 119 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 120 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 121 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 122 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 123 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 124 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 125 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 126 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 127 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 128 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 129 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 130 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 131 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 132 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 133 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 134 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 135 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 136 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 137 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 138 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 139 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 140 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 141 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 142 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 143 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 144 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 145 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 146 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 147 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 148 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 149 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 150 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 151 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 152 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 153 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 154 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 155 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 156 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 157 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 158 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 159 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 160 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 161 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 162 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 163 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 164 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 165 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 166 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 167 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 168 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 169 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 170 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 171 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 172 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 173 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 174 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 175 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 176 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 177 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 178 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 179 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 180 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 181 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 182 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236 Leading 10 Alopecia Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 237 Allergy therapeutics Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 238 Allergy therapeutics Alopecia Selected Recent Contracts 2019 (Date, Contract Disease Type, Details)
Table 239 Allergy therapeutics Alopecia Product Offering (Segment, Product Offerings)
Table 240 Sun Pharmaceutical Industries Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 241 Sun Pharmaceutical Industries Ltd. Alopecia Selected Recent Contracts 2019 (Date, Contract Disease Type, Details)
Table 242 Sun Pharmaceutical Industries Ltd. Alopecia Product Offering (Segment, Product Offerings)
Table 243 Cipla Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 244 Cipla Inc. Alopecia Selected Recent Contracts 2017-2019 (Date, Contract Disease Type, Details)
Table 245 Cipla Inc. Alopecia Product Offering (Segment, Product Offerings)
Table 246 Lexington International LLC Profile 2019 (CEO, HQ, Founded, Website)
Table 247 Lexington International LLC Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 248 Lexington International LLC Alopecia Product Offering (Segment, Product Offerings)
Table 249 Merck & Co., Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 250 Merck & Co., Inc. Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 251 Merck & Co., Inc. Alopecia Product Offering (Segment, Product Offerings)
Table 252 Vita-Cos-Med Klett-Loch GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 253 Vita-Cos-Med Klett-Loch GmbH Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 254 Vita-Cos-Med Klett-Loch GmbH Alopecia Product Offering (Segment, Product Offerings)
Table 255 Cirrus Hair Centers Profile 2019 (CEO, HQ, Founded, Website)
Table 256 Cirrus Hair Centers Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 257 Cirrus Hair Centers Alopecia Product Offering (Segment, Product Offerings)
Table 258 Transitions Hair Pty Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 259 Transitions Hair Pty Ltd. Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 260 Transitions Hair Pty Ltd. Alopecia Product Offering (Segment, Product Offerings)
Table 261 Capillus Profile 2019 (CEO, HQ, Founded, Website)
Table 262 Capillus Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 263 Capillus Alopecia Product Offering (Segment, Product Offerings)
Table 264 Follica, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 265 Follica, Inc. Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 266 Follica, Inc. Alopecia Product Offering (Segment, Product Offerings)
Table 267 Other Companies Involved in the Alopecia Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 Allergy Immunotherapy Market by Disease Type Overview
Figure 2 Allergy Immunotherapy Market by Route of Administration Overview
Figure 3 Allergy Immunotherapy Market by Distribution Channel Overview
Figure 4 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 5 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 6 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 7 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 8 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 9 Alopecia Market Drivers & Restraints 2020
Figure 10 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 11 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 12 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 13 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 14 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 15 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 16 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 17 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 18 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 19 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 20 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 40 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Figure 45 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 46 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 47 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 48 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 49 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 50 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 51 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 52 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 53 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 54 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 55 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 56 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 57 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 58 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 59 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 60 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 61 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 62 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 63 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 64 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 65 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 66 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 67 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 68 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 69 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 70 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 71 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 72 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 73 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 74 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 75 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 76 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 77 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 78 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 79 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 80 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 81 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 82 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 83 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 84 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 85 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 86 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 87 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 88 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 89 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 95 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 96 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 97 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 98 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 99 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 100 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 101 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 102 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 103 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 104 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 105 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 106 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 107 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 108 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 109 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 110 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 111 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 112 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 113 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 114 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 115 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 116 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 117 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 118 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 119 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 120 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 121 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 122 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 123 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 124 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 125 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 126 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 127 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 128 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 129 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 130 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 131 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 132 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 133 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 134 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 135 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 136 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 174 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 175 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 176 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 177 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 178 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 179 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 180 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 181 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 182 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 183 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 184 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 185 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 186 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 187 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 188 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 189 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 190 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 191 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 192 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 193 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 194 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 195 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 196 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 197 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 198 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 199 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 200 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 201 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 202 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 203 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 204 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 205 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 206 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 207 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 208 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 209 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 210 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 211 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 212 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 213 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 214 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 215 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 216 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 217 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 218 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 219 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 220 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 221 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 222 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 223 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 224 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 225 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 226 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 227 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 228 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 229 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 230 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 231 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 232 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 233 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 234 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 235 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 236 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 237 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 238 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Alopecia Market
2.1. Alopecia Market Definition
2.2. Disease Type Submarkets Definitions
2.3. Route of Administration Submarkets Definitions
2.4. Distribution Channel Submarkets Definitions
3. Alopecia Market Overview
3.1. Global Alopecia Market Size and Forecast by Region
3.2. Global Alopecia Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing global prevalence of alopecia
3.3.1.2. Growing incidence of chronic diseases
3.3.2. Market Restraints/Challenges
3.3.2.1. Lack of reimbursement policies
3.3.3. Opportunities
3.3.3.1. Rise in global healthcare expenditure
3.3.3.2. Technological advancements in alopecia treatment
3.3.4. Global Alopecia Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. The threat of New Entry
4. Global Alopecia Market Analysis and Forecast, 2021-2031 by Disease Type (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Androgenic Alopecia
4.1.2. Alopecia Areata
4.1.3. Ciatricial Alopecia
4.1.4. Traction Alopecia
4.1.5. Alopecia Totalis
5. Global Alopecia Market Analysis and Forecast 2021-2031, by Route of Administration (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Oral
5.1.2. Topical
5.1.3. Injectable
6. Global Alopecia Market Analysis and Forecast, 2021-2031 by Distribution Channel (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Hospital Pharmacy
6.1.2. Retail Pharmacy
6.1.3. Online Pharmacy
7. North America Alopecia Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Alopecia Market Size and Forecast by Disease Type
7.3. North America Alopecia Market Size and Forecast by Route of Administration
7.4. North America Alopecia Market Size and Forecast by Distribution Channel
7.5. U.S. Alopecia Market
7.6. Canada Alopecia Market
8. Europe Alopecia Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Alopecia Market Size and Forecast by Disease Type
8.3. Europe Alopecia Market Size and Forecast by Route of Administration
8.4. Europe Alopecia Market Size and Forecast by Distribution Channel
8.5. UK Alopecia Market
8.6. Germany Alopecia Market
8.7. France Alopecia Market
8.8. Rest of Europe Alopecia Market
9. Asia Pacific Alopecia Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Alopecia Market Size and Forecast by Disease Type
9.3. Asia Pacific Alopecia Market Size and Forecast by Route of Administration
9.4. Asia Pacific Alopecia Market Size and Forecast by Distribution Channel
9.5. China Alopecia Market
9.6. India Alopecia Market
9.7. Japan Alopecia Market
9.8. Rest of Asia Pacific Alopecia Market
10. Latin America Alopecia Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Alopecia Market Size and Forecast by Disease Type
10.3. Latin America Alopecia Market Size and Forecast by Route of Administration
10.4. Latin America Alopecia Market Size and Forecast by Distribution Channel
10.4.1. Brazil Alopecia Market
10.4.2. Mexico Alopecia Market
10.4.3. Rest of Latin America Alopecia Market
11. MEA Alopecia Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W, and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Alopecia Market Size and Forecast by Disease Type
11.3. MEA Alopecia Market Size and Forecast by Route of Administration
11.4. MEA Alopecia Market Size and Forecast by Distribution Channel
11.5. GCC Alopecia Market
11.6. South Africa Alopecia Market
11.7. Rest of MEA Alopecia Market
12. Companies in the Alopecia Market
12.1. Johnson and Johnson Services, Inc.
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2019)
12.2. Sun Pharmaceutical Industries Ltd.
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2019)
12.3. Cipla Inc.
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2019)
12.4. Lexington International LLC
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2019)
12.5. Merck & Co., Inc.
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2019)
12.6. Vita-Cos-Med Klett-Loch GmbH
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2019)
12.7. Cirrus Hair Centers
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2019)
12.8. Transitions Hair Pty Ltd.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2019)
12.9. Capillus
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2019)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2019
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2019)
12.10. Follica, Inc.
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2019
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2019)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6 Alopecia Market Drivers & Restraints 2020
Table 7 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 8 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 9 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 10 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 11 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 12 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 18 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 19 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 20 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 21 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 22 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 23 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 24 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 25 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 26 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 27 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 28 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 29 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 30 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 31 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 32 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 33 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 34 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 35 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 36 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 37 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 38 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 39 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 40 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 41 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Table 42 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 43 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 44 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 45 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 46 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 47 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 48 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 49 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 50 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 51 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 52 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 53 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 54 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 55 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 56 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 57 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 58 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 59 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 60 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 61 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 62 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 63 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 64 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 65 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 66 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 67 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 68 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 69 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 70 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 71 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 72 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 73 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 74 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 75 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 76 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 77 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 78 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 79 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 80 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 81 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 82 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 83 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 84 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 85 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 86 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 87 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 88 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 89 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 90 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 91 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 92 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 93 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 94 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 95 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 96 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 97 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 98 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 99 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 100 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 101 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 102 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 103 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 104 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 105 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 106 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 107 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 108 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 109 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 110 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 111 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 112 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 113 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 114 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 115 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 116 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 117 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 118 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 119 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 120 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 121 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 122 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 123 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 124 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 125 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 126 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 127 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 128 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 129 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 130 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 131 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 132 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 133 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 134 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 135 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 136 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 137 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 138 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 139 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 140 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 141 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 142 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 143 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 144 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 145 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 146 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 147 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 148 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 149 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 150 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 151 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 152 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 153 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 154 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 155 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 156 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 157 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 158 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 159 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 160 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 161 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 162 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 163 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 164 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 165 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 166 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 167 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 168 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 169 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 170 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 171 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 172 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 173 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 174 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 175 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 176 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 177 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 178 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 179 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 180 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 181 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 182 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 190 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 191 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 192 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 193 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 194 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 195 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 196 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 197 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 198 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 199 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236 Leading 10 Alopecia Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 237 Allergy therapeutics Corporation Profile 2019 (CEO, HQ, Founded, Website)
Table 238 Allergy therapeutics Alopecia Selected Recent Contracts 2019 (Date, Contract Disease Type, Details)
Table 239 Allergy therapeutics Alopecia Product Offering (Segment, Product Offerings)
Table 240 Sun Pharmaceutical Industries Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 241 Sun Pharmaceutical Industries Ltd. Alopecia Selected Recent Contracts 2019 (Date, Contract Disease Type, Details)
Table 242 Sun Pharmaceutical Industries Ltd. Alopecia Product Offering (Segment, Product Offerings)
Table 243 Cipla Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 244 Cipla Inc. Alopecia Selected Recent Contracts 2017-2019 (Date, Contract Disease Type, Details)
Table 245 Cipla Inc. Alopecia Product Offering (Segment, Product Offerings)
Table 246 Lexington International LLC Profile 2019 (CEO, HQ, Founded, Website)
Table 247 Lexington International LLC Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 248 Lexington International LLC Alopecia Product Offering (Segment, Product Offerings)
Table 249 Merck & Co., Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 250 Merck & Co., Inc. Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 251 Merck & Co., Inc. Alopecia Product Offering (Segment, Product Offerings)
Table 252 Vita-Cos-Med Klett-Loch GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 253 Vita-Cos-Med Klett-Loch GmbH Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 254 Vita-Cos-Med Klett-Loch GmbH Alopecia Product Offering (Segment, Product Offerings)
Table 255 Cirrus Hair Centers Profile 2019 (CEO, HQ, Founded, Website)
Table 256 Cirrus Hair Centers Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 257 Cirrus Hair Centers Alopecia Product Offering (Segment, Product Offerings)
Table 258 Transitions Hair Pty Ltd. Profile 2019 (CEO, HQ, Founded, Website)
Table 259 Transitions Hair Pty Ltd. Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 260 Transitions Hair Pty Ltd. Alopecia Product Offering (Segment, Product Offerings)
Table 261 Capillus Profile 2019 (CEO, HQ, Founded, Website)
Table 262 Capillus Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 263 Capillus Alopecia Product Offering (Segment, Product Offerings)
Table 264 Follica, Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 265 Follica, Inc. Alopecia Selected Recent Contracts 2015-2019 (Date, Contract Disease Type, Details)
Table 266 Follica, Inc. Alopecia Product Offering (Segment, Product Offerings)
Table 267 Other Companies Involved in the Alopecia Market 2020 (Company, Location)
LIST OF FIGURES
Figure 1 Allergy Immunotherapy Market by Disease Type Overview
Figure 2 Allergy Immunotherapy Market by Route of Administration Overview
Figure 3 Allergy Immunotherapy Market by Distribution Channel Overview
Figure 4 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 5 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 6 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 7 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 8 Alopecia Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 9 Alopecia Market Drivers & Restraints 2020
Figure 10 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 11 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 12 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 13 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 14 Alopecia Market Forecast by Disease Type 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 15 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 16 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 17 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 18 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 19 Androgenic Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 20 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23 Alopecia Areata Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28 Ciatricial Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33 Traction Alopecia Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38 Alopecia Totalis Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 40 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 41 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 42 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 43 Alopecia Submarket Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 44 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) before COVID)
Figure 45 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 46 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 47 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 48 Oral Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 49 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 50 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 51 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 52 Topical Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 53 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 54 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 55 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 56 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 57 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 58 Injectable Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 59 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 60 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 61 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 62 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 63 Alopecia Market Forecast by Distribution Channel 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 64 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 65 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 66 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 67 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 68 Hospital Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 69 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 70 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 71 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 72 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 73 Retail Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 74 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 75 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 76 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 77 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 78 Online Pharmacy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 79 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 80 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 81 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 82 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 83 Regional Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 84 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 85 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 86 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 87 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 88 North America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 89 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93 North America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 95 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 96 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 97 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 98 North America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 99 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 100 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 101 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 102 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 103 North America Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 104 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 105 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 106 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 107 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 108 US Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 109 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 110 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 111 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 112 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 113 Canada Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 114 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 115 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 116 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 117 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 118 Europe Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 119 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 120 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 121 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 122 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 123 Europe Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 124 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 125 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 126 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 127 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 128 Europe Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 129 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 130 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 131 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 132 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 133 Europe Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 134 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 135 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 136 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138 UK Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143 Germany Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148 France Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153 Rest of Europe Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158 Asia Pacific Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163 Asia Pacific Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168 Asia Pacific Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173 Asia Pacific Alopecia Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 174 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 175 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 176 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 177 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 178 China Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 179 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 180 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 181 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 182 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 183 India Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 184 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 185 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 186 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 187 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 188 Japan Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 189 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 190 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 191 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 192 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 193 RoAPAC Alopecia Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 194 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 195 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 196 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 197 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 198 Middle East Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 199 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 200 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 201 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 202 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 203 Middle East Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 204 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 205 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 206 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 207 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 208 Middle East Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 209 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 210 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 211 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 212 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 213 Latin America Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 214 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 215 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 216 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 217 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 218 Latin America Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 219 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 220 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 221 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 222 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 223 Latin America Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 224 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 225 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 226 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 227 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 228 Africa Alopecia Market Forecast by Disease Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 229 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 230 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 231 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 232 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 233 Africa Alopecia Market Forecast by Route of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 234 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 235 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 236 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 237 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 238 Africa Alopecia Market Forecast by Distribution Channel 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Companies Profiled in the Report
1. Johnson and Johnson Services, Inc.
2. Sun Pharmaceutical Industries Ltd.
3. Cipla Inc.
4. Lexington International LLC
5. Merck & Co., Inc.
6. Vita-Cos-Med Klett-Loch GmbH
7. Cirrus Hair Centers
8. Transitions Hair Pty Ltd.
9. Capillus
10. Follica, Inc.
List of Companies Mentioned in the Report:
1. Shionogi & Co.
2. Shanghai Fosun Pharmaceutical
3. Stada Arzneimittel
4. Lundbeck
5. Zhejiang International
6. Lupin
7. Taisho Pharmaceutical
8. Tasly Pharmaceutical
9. Ipsen
10. Sino Biopharmaceutical
11. Ono Pharmaceutical
12. Aurobindo
13. Cipla
14. Johnson & Johnson
15. Roche
16. Novartis
17. Sanofi
18. Bayer
19. Merck & Co. (MSD)
20. Eli Lilly
21. Astrazeneca
22. Teva
23. CR Pharmaceutical
24. Bristol-Myers Squibb
25. Merck (KGaA)
26. Novo Nordisk
27. Takeda
28. Allergan
29. Astellas Pharma
30. Mylan
31. Otsuka
32. Daiichi Sankyo
33. Valeant Pharmaceuticals
34. UCB
35. Zoetis
36. Eisai
37. Chugai Pharmaceutical
38. Perrigo
39. Sun Pharmaceutical
40. Mitsubishi Tanabe Pharma
41. Sichuan Languang Development
42. Sumitomo Dainippon Pharma
43. Yunnan Baiyao
44. Aspen Pharmacare
45. Endo
46. Kangmei Pharmaceutical
47. Galenica
48. Guangzhou Baiyunshan Pharmaceutical
49. Kyowa Hakko Kirin
50. Mallinckrod
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
1. Johnson and Johnson Services, Inc.
2. Sun Pharmaceutical Industries Ltd.
3. Cipla Inc.
4. Lexington International LLC
5. Merck & Co., Inc.
6. Vita-Cos-Med Klett-Loch GmbH
7. Cirrus Hair Centers
8. Transitions Hair Pty Ltd.
9. Capillus
10. Follica, Inc.
List of Companies Mentioned in the Report:
1. Shionogi & Co.
2. Shanghai Fosun Pharmaceutical
3. Stada Arzneimittel
4. Lundbeck
5. Zhejiang International
6. Lupin
7. Taisho Pharmaceutical
8. Tasly Pharmaceutical
9. Ipsen
10. Sino Biopharmaceutical
11. Ono Pharmaceutical
12. Aurobindo
13. Cipla
14. Johnson & Johnson
15. Roche
16. Novartis
17. Sanofi
18. Bayer
19. Merck & Co. (MSD)
20. Eli Lilly
21. Astrazeneca
22. Teva
23. CR Pharmaceutical
24. Bristol-Myers Squibb
25. Merck (KGaA)
26. Novo Nordisk
27. Takeda
28. Allergan
29. Astellas Pharma
30. Mylan
31. Otsuka
32. Daiichi Sankyo
33. Valeant Pharmaceuticals
34. UCB
35. Zoetis
36. Eisai
37. Chugai Pharmaceutical
38. Perrigo
39. Sun Pharmaceutical
40. Mitsubishi Tanabe Pharma
41. Sichuan Languang Development
42. Sumitomo Dainippon Pharma
43. Yunnan Baiyao
44. Aspen Pharmacare
45. Endo
46. Kangmei Pharmaceutical
47. Galenica
48. Guangzhou Baiyunshan Pharmaceutical
49. Kyowa Hakko Kirin
50. Mallinckrod
List of Organizations Mentioned in the Report:
1. European Commission
2. European Medicines Agency
3. Food and Drug Administration
4. Medicines and Healthcare Regulatory Agency
5. Ministry of Industry and Information technology
6. National Institute of Health
7. World Health Organisation (WHO)
8. Centers for Disease Control and Prevention
9. National Academy of Medicine
10. Agency for Healthcare Research and Quality
11. National Accreditation Board for Hospitals & Healthcare Providers
12. National Institute for Health Research
13. Chinese Food and Drug Administration
14. Care Quality Commission
15. British Medical Association
16. United States Department of Health and Human Services
17. Healthcare Information and Management Systems Society
18. Patient safety organization
19. NHS Digital
20. Australian Commission On Safety And Quality In Health Care
Download sample pages
Complete the form below to download your free sample pages for Alopecia Market Report to 2031Download sample pages
Complete the form below to download your free sample pages for Alopecia Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Bioreactors Market Report 2023-2033
The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
29 September 2023
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
27 September 2023
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
25 September 2023
Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
21 September 2023
